NEW YORK (GenomeWeb) – German start-up SpinDiag said on Thursday that it has raised €1.6 million ($1.9 million) in seed funding.

The financing came from three unnamed private investors and will be used to bring its point-of-care screening system to hospitals from its current laboratory environment, the firm said. The technology called SpinDiag one, is being developed for hospital screening of all clinically relevant antibiotic-resistant bacteria at the time patients are admitted.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.